Lin Tong, Xie Bingqin, Yang Juan, Xu Jinbang, Chen Fa
Department of Traditional Chinese Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China.
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.
Reprod Health. 2025 May 20;22(1):86. doi: 10.1186/s12978-025-02016-y.
Polycystic ovary syndrome (PCOS) is a chronic, multifaceted condition influenced by epigenetic and environmental factors that is responsible for a significant proportion of anovulatory infertility cases. Here, we analyzed the global, regional, and national burdens of PCOS from 1990 to 2021 using data from the Global Burden of Disease 2021 (GBD 2021).
Incidence, prevalence, and Disability-Adjusted Life Years (DALYs) data relevant to PCOS from 204 countries and 21 territories from 1990 to 2021 were obtained from the GBD 2021 study. Here, we considered age-standardized rates (per 100,000 individuals) with 95% uncertainty intervals (95% UIs) obtained from the aforementioned research and presented trends based on age and Socio-demographic Index (SDI) parameters.
In 2021, the global age-standardized incidence and prevalence rates of PCOS were 30.7 per 100,000 and 867.7 per 100,000, respectively, representing an increase of 26.77% and 28.21% since 1990. Additionally, age-standardized disability-adjusted life years stood at 7.6 per 100,000 globally in 2021, marking a 27.58% increase from 1990. Age-standardized prevalence of PCOS varied across countries, ranging from 93.1 to 3978.9 cases per 100,000 women, with Italy (3978.9), Japan (3104.7), and New Zealand (2789.7) having the highest rates. Notably, PCOS prevalence was noted to peak globally among females 15-19 years of age. Regions with a high SDI exhibited the highest age-standardized incidence (70.2), prevalence (1720.7), and DALY (15.2) rates of PCOS. Furthermore, a nonlinear correlation between PCOS burden and SDI was noted, with prevalence rates peaking around an SDI of approximately 0.9.
Our findings highlight the growing global impact of PCOS and underscore the need for concerted efforts to attenuate the increasing global prevalence of this condition. Significantly divergent PCOS disease burdens were observed across different age groups and SDI regions, with high SDI regions bearing heavier burdens. The increased disease burden among younger age groups and regional disparities underscore urgency for targeted intervention and formulation of policies to effectively address this public health issue.
多囊卵巢综合征(PCOS)是一种受表观遗传和环境因素影响的慢性、多方面疾病,导致了相当比例的无排卵性不孕病例。在此,我们利用《2021年全球疾病负担》(GBD 2021)的数据,分析了1990年至2021年期间PCOS的全球、区域和国家负担。
从GBD 2021研究中获取了1990年至2021年期间204个国家和21个地区与PCOS相关的发病率、患病率和伤残调整生命年(DALYs)数据。在此,我们考虑了从上述研究中获得的年龄标准化率(每10万人)及95%不确定性区间(95% UIs),并根据年龄和社会人口指数(SDI)参数呈现了趋势。
2021年,全球PCOS的年龄标准化发病率和患病率分别为每10万人30.7例和每10万人867.7例,自1990年以来分别增长了26.77%和28.21%。此外,2021年全球年龄标准化伤残调整生命年为每10万人7.6,比1990年增长了27.58%。PCOS的年龄标准化患病率在各国有所不同,每10万名女性中从93.1例到3978.9例不等,意大利(3978.9)、日本(3104.7)和新西兰(2789.7)的患病率最高。值得注意的是,全球PCOS患病率在15 - 19岁女性中达到峰值。高SDI地区的PCOS年龄标准化发病率(70.2)、患病率(1720.7)和DALY(15.2)率最高。此外,还注意到PCOS负担与SDI之间存在非线性相关性,患病率在SDI约为0.9时达到峰值。
我们的研究结果凸显了PCOS对全球的影响日益增加,并强调需要共同努力减轻这种疾病在全球范围内不断上升的患病率。在不同年龄组和SDI地区观察到PCOS疾病负担存在显著差异,高SDI地区负担更重。年轻年龄组疾病负担的增加和地区差异凸显了针对性干预和制定政策以有效解决这一公共卫生问题的紧迫性。